In the preceding three months, 7 analysts have released ratings for Enovix ENVX, presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 4 | 1 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 2 | 2 | 1 | 0 | 0 |
Analysts have set 12-month price targets for Enovix, revealing an average target of $22.0, a high estimate of $36.00, and a low estimate of $14.00. This current average has increased by 2.66% from the previous average price target of $21.43.
Breaking Down Analyst Ratings: A Detailed Examination
The perception of Enovix by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Bill Peterson | JP Morgan | Lowers | Overweight | $15.00 | $18.00 |
Colin Rusch | Oppenheimer | Maintains | Outperform | $36.00 | $36.00 |
Alexander Potter | Piper Sandler | Lowers | Overweight | $19.00 | $23.00 |
Gabe Daoud | TD Cowen | Raises | Hold | $14.00 | $11.00 |
Derek Soderberg | Cantor Fitzgerald | Maintains | Overweight | $30.00 | $30.00 |
Anthony Stoss | Craig-Hallum | Raises | Buy | $20.00 | $15.00 |
George Gianarikas | Canaccord Genuity | Raises | Buy | $20.00 | $17.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Enovix. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Enovix compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Enovix's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Enovix analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Unveiling the Story Behind Enovix
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Enovix: Financial Performance Dissected
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Enovix's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 8871.43%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Enovix's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -3075.16%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Enovix's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -58.0%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Enovix's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -23.22%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.14, caution is advised due to increased financial risk.
The Significance of Analyst Ratings Explained
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.